These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 25790347)

  • 41. Successful treatment of subungual fibromas of tuberous sclerosis with topical rapamycin.
    Muzic JG; Kindle SA; Tollefson MM
    JAMA Dermatol; 2014 Sep; 150(9):1024-5. PubMed ID: 24919623
    [No Abstract]   [Full Text] [Related]  

  • 42. Current options for the treatment of facial angiofibromas.
    Salido-Vallejo R; Garnacho-Saucedo G; Moreno-Giménez JC
    Actas Dermosifiliogr; 2014; 105(6):558-68. PubMed ID: 23522741
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sirolimus for the treatment of juvenile nasopharyngeal angiofibroma.
    Fernández KS; de Alarcon A; Adams DM; Hammill AM
    Pediatr Blood Cancer; 2020 Apr; 67(4):e28162. PubMed ID: 31925925
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Topical rapamycin in the treatment of facial angiofibromas in tuberous sclerosis: a systematic review based on evidence.
    Cortell Fuster C; Martínez Gómez MA; Cercós Lleti AC; Climente Martí M
    J Dermatolog Treat; 2022 Jun; 33(4):1804-1810. PubMed ID: 33821748
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rapamycin therapy for renal, brain, and skin lesions in a tuberous sclerosis patient.
    Micozkadioglu H; Koc Z; Ozelsancak R; Yildiz I
    Ren Fail; 2010; 32(10):1233-6. PubMed ID: 20954988
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Topical everolimus for facial angiofibromas in the tuberous sclerosis complex. A first case report.
    Dill PE; De Bernardis G; Weber P; Lösch U
    Pediatr Neurol; 2014 Jul; 51(1):109-13. PubMed ID: 24810875
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rapamycin (sirolimus) in tuberous sclerosis associated pediatric central nervous system tumors.
    Lam C; Bouffet E; Tabori U; Mabbott D; Taylor M; Bartels U
    Pediatr Blood Cancer; 2010 Mar; 54(3):476-9. PubMed ID: 19856393
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of Angiofibromas in a Tuberous Sclerosis Patient Using Topical Timolol 0.5% Gel.
    Krakowski AC; Nguyen TA
    Pediatrics; 2015 Sep; 136(3):e709-13. PubMed ID: 26304829
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Topical rapamycin combined with calcitriol in treating angiofibromas in tuberous sclerosis complex.
    Lee CH
    Br J Dermatol; 2020 Oct; 183(4):604-606. PubMed ID: 32338383
    [No Abstract]   [Full Text] [Related]  

  • 50. Analysis of current data on the use of topical mTOR inhibitors in the treatment of facial angiofibromas in tuberous sclerosis complex-An update.
    Balestri R; Rizzoli L; Pedrolli A; Urru SAM; Rech G; Neri I; Girardelli CR; Magnano M
    J Eur Acad Dermatol Venereol; 2023 Mar; 37(3):474-487. PubMed ID: 36300771
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Familial multiple discoid fibromas: unique histological features and therapeutic response to topical rapamycin.
    Wee JS; Chong H; Natkunarajah J; Mortimer PS; Moosa Y
    Br J Dermatol; 2013 Jul; 169(1):177-80. PubMed ID: 23495951
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of infantile hemangiomas with sirolimus in a patient with PHACE syndrome.
    Kaylani S; Theos AJ; Pressey JG
    Pediatr Dermatol; 2013; 30(6):e194-7. PubMed ID: 23316753
    [TBL] [Abstract][Full Text] [Related]  

  • 53. First Japanese case of trichoepithelioma papulosum multiplex successfully treated with sirolimus gel.
    Shimizu A; Toyoda A; Motegi SI; Yasuda M; Ishikawa O
    J Dermatol; 2020 May; 47(5):e197-e198. PubMed ID: 32077127
    [No Abstract]   [Full Text] [Related]  

  • 54. Antitumoral activity of rapamycin in renal angiomyolipoma associated with tuberous sclerosis complex.
    Wienecke R; Fackler I; Linsenmaier U; Mayer K; Licht T; Kretzler M
    Am J Kidney Dis; 2006 Sep; 48(3):e27-9. PubMed ID: 16931204
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Classic Kaposi's sarcoma treated with topical rapamycin.
    Díaz-Ley B; Grillo E; Ríos-Buceta L; Paoli J; Moreno C; Vano-Galván S; Jaén-Olasolo P
    Dermatol Ther; 2015; 28(1):40-3. PubMed ID: 25314592
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A case of microcystic lymphatic malformation successfully treated with topical sirolimus.
    Çalışkan E; Altunel CT; Özkan CK; Tunca M
    Dermatol Ther; 2018 Sep; 31(5):e12673. PubMed ID: 30133999
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sirolimus and tuberous sclerosis-associated renal angiomyolipomas.
    Krischock L; Beach R; Taylor J
    Arch Dis Child; 2010 May; 95(5):391-2. PubMed ID: 20457704
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Novel treatment of painful plantar keratoderma in pachyonychia congenita using topical sirolimus.
    Teng JMC; Bartholomew FB; Patel V; Sun G
    Clin Exp Dermatol; 2018 Dec; 43(8):968-971. PubMed ID: 29882237
    [No Abstract]   [Full Text] [Related]  

  • 59. Topical sirolimus 1% for benign lymphangiomatous papules after radiotherapy for endometrial and breast cancers: a report of three cases.
    Leducq S; Gabeff R; Zaragoza J; Poiraud C; Tallegas M; Maruani A
    Eur J Dermatol; 2021 Apr; 31(2):252-254. PubMed ID: 34001474
    [No Abstract]   [Full Text] [Related]  

  • 60. Topical rapamycin (sirolimus) for the treatment of uncomplicated tufted angiomas in two children and review of the literature.
    Burleigh A; Kanigsberg N; Lam JM
    Pediatr Dermatol; 2018 Sep; 35(5):e286-e290. PubMed ID: 30015406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.